Literature DB >> 3759943

The complete cDNA and amino acid sequence of human apolipoprotein B-100.

S H Chen, C Y Yang, P F Chen, D Setzer, M Tanimura, W H Li, A M Gotto, L Chan.   

Abstract

We have determined the complete sequence of apolipoprotein (apo) B-100 cDNA. It is 14.1 kilobases in length and codes for a 4563-amino acid protein, including a 27-amino acid signal peptide and a 4536-amino acid mature protein. Further, we identified 2366 residues of apoB-100 by direct sequence analysis of apoB-100 tryptic peptides. The mature peptide is characterized by high hydrophobicity (0.916 kcal/residue) and predicted beta-sheet content (21%). Dot matrix analysis revealed the presence of many long internal repeats in apoB-100. The mature peptide contains 25 cysteine residues, 12 of which are in the N-terminal 500 residues. Twenty potential N-linked glycosylation sites were identified, of which 13 were proven to be glycosylated, and 4 were found not to be glycosylated by direct analysis of tryptic peptides. Our findings on apoB structure provide a basis for future experimentation on the role of apoB-100-containing lipoproteins in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3759943

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Tandem mass spectrometric characterization of a specific cysteic acid residue in oxidized human apoprotein B-100.

Authors:  O Burlet; C Y Yang; J R Guyton; S J Gaskell
Journal:  J Am Soc Mass Spectrom       Date:  1995-04       Impact factor: 3.109

2.  Post-translational modification of apolipoprotein B by transglutaminases.

Authors:  E Cocuzzi; M Piacentini; S Beninati; S I Chung
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

3.  Inference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred.

Authors:  M Leppert; J L Breslow; L Wu; S Hasstedt; P O'Connell; M Lathrop; R R Williams; R White; J M Lalouel
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

4.  Conformation and stability properties of B17: II. Analytical investigations using differential scanning calorimetry.

Authors:  Hassan M Khachfe; David Atkinson
Journal:  Eur Biophys J       Date:  2012-12-28       Impact factor: 1.733

5.  Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region.

Authors:  E Boerwinkle; W J Xiong; E Fourest; L Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  DNase I- and micrococcal nuclease-hypersensitive sites in the human apolipoprotein B gene are tissue specific.

Authors:  B Levy-Wilson; C Fortier; B D Blackhart; B J McCarthy
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

7.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 8.  Apolipoproteins and metabolism in atherosclerosis.

Authors:  A M Gotto
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

Review 9.  Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy.

Authors:  C M Ballantyne; L Chan; J Guevara; J D Morrisett; M P Mims; A M Gotto
Journal:  Tex Heart Inst J       Date:  1994

10.  Structural relationship of human apolipoprotein B48 to apolipoprotein B100.

Authors:  T L Innerarity; S G Young; K S Poksay; R W Mahley; R S Smith; R W Milne; Y L Marcel; K H Weisgraber
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.